ENLIVEN THERAPEUTICS, INC. CONSULTING AGREEMENTConsulting Agreement • January 9th, 2023 • IMARA Inc. • Pharmaceutical preparations • California
This Consulting Agreement (this “Agreement”) is made and entered into as of January 8, 2020 (the “Effective Date”) by and between EnLiven Therapeutics, Inc., a Delaware corporation with its principal place of business at 496 Crestlake Dr., San Francisco, CA 94132 (the “Company”), and Richard Heyman, an individual with a principal address at [***] (“Consultant”) (each herein referred to individually as a “Party,” or collectively as the “Parties”).
